🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anǵela Tincani

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

ORCID: 0000-0003-4355-9333

Also affiliated with University of Brescia

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)”.

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Journal of Thrombosis and Haemostasis(2006)10.1111/j.1538-7836.2006.01753.x

N/A

1.3DataRank · unranked

7085 citations

M.D. LOCKSHIN, T. ATSUMI, D.W. BRANCH, R.L. BREY, R Cervera +23 more

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

Annals of the Rheumatic Diseases(2008)10.1136/ard.2007.070367

N/A

0.994DataRank · unranked

753 citations

J. Boletis, S Bombardieri, R Cervera, C Dostal, J Font +28 more

Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis

Lara D. Veeken(2020)10.1093/rheumatology/keaa767

N/A

0.668DataRank · unranked

21 citations

Gabriella Moroni, Renato Alberto Sinico, Franco Franceschini, Micaela Fredi, Augusto Vaglio +34 more

Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study

The Lancet Rheumatology(2022)10.1016/s2665-9913(22)00107-2

N/A

0.624DataRank · unranked

63 citations

Elisabetta Chessa, Eric F. Morand, Manuel F. Ugarte‐Gil, Maria G. Tektonidou, Ronald van Vollenhoven +77 more

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus

Annals of the Rheumatic Diseases(2009)10.1136/ard.2007.083022

N/A

0.587DataRank · unranked

49 citations

G K Bertsias, J. Boletis, S Bombardieri, R Cervera, C Dostal +30 more

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

Annals of the Rheumatic Diseases(2009)10.1136/ard.2007.083030

N/A

0.515DataRank · unranked

30 citations

J. Boletis, S Bombardieri, R Cervera, C Dostal, J Font +30 more

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Laboratory Investigation(2023)10.1016/j.labinv.2023.100147

N/A

0.312DataRank · unranked

7 citations

Rohan Willis, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza +67 more

Second Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus

Kidney360(2025)10.34067/kid.0000000738

N/A

0DataRank · unranked

0 citations

Cameron Miller, Amanda M. Eudy, Rachel A. Myers, Christina Wyatt, Sarahn M. Wheeler +12 more

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

Frontiers in Immunology(2020)10.3389/fimmu.2020.584241

N/A

0DataRank · unranked

177 citations

Asmaa Beltagy, Emirena Garrafa, Daniele Curreli, Germana Cecchini, Caterina Bodio +22 more

Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome

medRxiv(2020)10.1101/2020.06.17.20134114

N/A

0DataRank · unranked

37 citations

Asmaa Beltagy, Emirena Garrafa, Daniele Curreli, Germana Cecchini, Caterina Bodio +22 more

COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)

Lupus(2021)10.1177/09612033211062523

N/A

0DataRank · unranked

30 citations

Elena Gkrouzman, Danieli Andrade, Laura Andréoli, Medha Barbhaiya, H. Michael Belmont +22 more

Hydroxychloroquine in the Pregnancies of Women with Lupus: A Meta-Analysis of Individual Participant Data

medRxiv(2021)10.1101/2021.12.21.21267285

N/A

0DataRank · unranked

5 citations

Amanda M. Eudy, Stephen J. Balevic, Gillian Sanders-Schmidler, Andrzej S. Kosinski, Rebecca Fischer‐Betz +10 more

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Lara D. Veeken(2023)10.1093/rheumatology/kead292

N/A

0DataRank · unranked

18 citations

Yasaman Ahmadzadeh, Maria G. Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte +64 more

Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

The Lancet Rheumatology(2025)10.1016/s2665-9913(25)00257-7

N/A

0DataRank · unranked

1 citations

Anne Grete Semb, Michelle Petri, Petros P. Sfikakis, Bahar Artım-Esen, Gabriela Hernández‐Molina +21 more